FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2519868139> ?p ?o ?g. }

• W2519868139 endingPage "1017" @default.
• W2519868139 startingPage "1011" @default.
• W2519868139 abstract "Data from clinical trials in adults, extrapolated to predict benefits in paediatric patients, could result in fewer or smaller trials being required to obtain a new drug licence for paediatrics. This article outlines the place of such extrapolation in the development of drugs for use in paediatric epilepsies. Based on consensus expert opinion, a proposal is presented for a new paradigm for the clinical development of drugs for focal epilepsies. Phase I data should continue to be collected in adults, and phase II and III trials should simultaneously recruit adults and paediatric patients aged above 2 years. Drugs would be provisionally licensed for children subject to phase IV collection of neurodevelopmental safety data in this age group. A single programme of trials would suffice to license the drug for use as either adjunctive therapy or monotherapy. Patients, clinicians and sponsors would all benefit from this new structure through cost reduction and earlier access to novel treatments. Further work is needed to elicit the views of patients, their parents and guardians as appropriate, regulatory authorities and bodies such as the National Institute for Health and Care Excellence (UK)." @default.
• W2519868139 created "2016-09-23" @default.
• W2519868139 creator A5000013257 @default.
• W2519868139 creator A5000389618 @default.
• W2519868139 creator A5005069325 @default.
• W2519868139 creator A5011085036 @default.
• W2519868139 creator A5026218987 @default.
• W2519868139 creator A5027669652 @default.
• W2519868139 creator A5030773129 @default.
• W2519868139 creator A5039053181 @default.
• W2519868139 creator A5053252382 @default.
• W2519868139 creator A5056673244 @default.
• W2519868139 creator A5088779446 @default.
• W2519868139 date "2016-09-13" @default.
• W2519868139 modified "2023-10-12" @default.
• W2519868139 title "Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation" @default.
• W2519868139 cites W1966204708 @default.
• W2519868139 cites W1972971137 @default.
• W2519868139 cites W1973802256 @default.
• W2519868139 cites W1980717880 @default.
• W2519868139 cites W1991760478 @default.
• W2519868139 cites W1999919778 @default.
• W2519868139 cites W2010024475 @default.
• W2519868139 cites W2030113059 @default.
• W2519868139 cites W2030402949 @default.
• W2519868139 cites W2031263002 @default.
• W2519868139 cites W2043521772 @default.
• W2519868139 cites W2053779019 @default.
• W2519868139 cites W2108493868 @default.
• W2519868139 cites W2123828545 @default.
• W2519868139 cites W2134306772 @default.
• W2519868139 cites W2138521331 @default.
• W2519868139 cites W2147974822 @default.
• W2519868139 cites W2170623128 @default.
• W2519868139 cites W2171386011 @default.
• W2519868139 cites W2493712194 @default.
• W2519868139 cites W4235275633 @default.
• W2519868139 cites W4240233071 @default.
• W2519868139 cites W651652324 @default.
• W2519868139 doi "https://doi.org/10.1007/s40263-016-0383-y" @default.
• W2519868139 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5078157" @default.
• W2519868139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27623676" @default.
• W2519868139 hasPublicationYear "2016" @default.
• W2519868139 type Work @default.
• W2519868139 sameAs 2519868139 @default.
• W2519868139 citedByCount "13" @default.
• W2519868139 countsByYear W25198681392017 @default.
• W2519868139 countsByYear W25198681392018 @default.
• W2519868139 countsByYear W25198681392019 @default.
• W2519868139 countsByYear W25198681392020 @default.
• W2519868139 countsByYear W25198681392021 @default.
• W2519868139 countsByYear W25198681392022 @default.
• W2519868139 crossrefType "journal-article" @default.
• W2519868139 hasAuthorship W2519868139A5000013257 @default.
• W2519868139 hasAuthorship W2519868139A5000389618 @default.
• W2519868139 hasAuthorship W2519868139A5005069325 @default.
• W2519868139 hasAuthorship W2519868139A5011085036 @default.
• W2519868139 hasAuthorship W2519868139A5026218987 @default.
• W2519868139 hasAuthorship W2519868139A5027669652 @default.
• W2519868139 hasAuthorship W2519868139A5030773129 @default.
• W2519868139 hasAuthorship W2519868139A5039053181 @default.
• W2519868139 hasAuthorship W2519868139A5053252382 @default.
• W2519868139 hasAuthorship W2519868139A5056673244 @default.
• W2519868139 hasAuthorship W2519868139A5088779446 @default.
• W2519868139 hasBestOaLocation W25198681392 @default.
• W2519868139 hasConcept C118552586 @default.
• W2519868139 hasConcept C142724271 @default.
• W2519868139 hasConcept C17744445 @default.
• W2519868139 hasConcept C177713679 @default.
• W2519868139 hasConcept C187212893 @default.
• W2519868139 hasConcept C199539241 @default.
• W2519868139 hasConcept C2777352838 @default.
• W2519868139 hasConcept C2778186239 @default.
• W2519868139 hasConcept C2778802184 @default.
• W2519868139 hasConcept C2780035454 @default.
• W2519868139 hasConcept C512399662 @default.
• W2519868139 hasConcept C535046627 @default.
• W2519868139 hasConcept C64903051 @default.
• W2519868139 hasConcept C71924100 @default.
• W2519868139 hasConceptScore W2519868139C118552586 @default.
• W2519868139 hasConceptScore W2519868139C142724271 @default.
• W2519868139 hasConceptScore W2519868139C17744445 @default.
• W2519868139 hasConceptScore W2519868139C177713679 @default.
• W2519868139 hasConceptScore W2519868139C187212893 @default.
• W2519868139 hasConceptScore W2519868139C199539241 @default.
• W2519868139 hasConceptScore W2519868139C2777352838 @default.
• W2519868139 hasConceptScore W2519868139C2778186239 @default.
• W2519868139 hasConceptScore W2519868139C2778802184 @default.
• W2519868139 hasConceptScore W2519868139C2780035454 @default.
• W2519868139 hasConceptScore W2519868139C512399662 @default.
• W2519868139 hasConceptScore W2519868139C535046627 @default.
• W2519868139 hasConceptScore W2519868139C64903051 @default.
• W2519868139 hasConceptScore W2519868139C71924100 @default.
• W2519868139 hasFunder F4320319990 @default.
• W2519868139 hasFunder F4320334626 @default.
• W2519868139 hasIssue "11" @default.
• W2519868139 hasLocation W25198681391 @default.
• W2519868139 hasLocation W25198681392 @default.

• next